SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing intense bullish momentum, driven by spot silver prices reaching new all-time highs. This rally is fueled by tightening global supply due to upcoming Chinese export restrictions, alongside booming industrial demand from EV batteries, solar, and AI data centers. The community is actively discussing a potential 'silver squeeze' and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is actively trending following the FDA approval of YARTEMLEA, a groundbreaking therapy for transplant-associated thrombotic microangiopathy, which is the first and only approved treatment for the condition. The community is buzzing with enthusiasm, anticipating significant value appreciation and a potential short squeeze, further bolstered by the company's substantial partnership with Novo Nordisk.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony (UAMY) is trending amid escalating geopolitical tensions driving the US government's urgent push for domestic critical mineral independence, especially following China's tightened export controls on antimony. The community is buzzing about UAMY's unique position as the sole US provider of military-grade antimony, reinforced by significant defense contracts and ongoing capacity expansion. Despite recent price volatility, investors are anticipating major government grants or an acquisition, believing the stock remains significantly undervalued given its strategic importance.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as strategic moves in AI and autonomous technology draw significant attention. The company's acquisition of Intersect Power reinforces its commitment to scaling AI infrastructure, complemented by high valuation discussions for its Waymo autonomous driving unit. Community sentiment is largely bullish, recognizing Gemini's growing market share against rivals and Alphabet's strong position as a leading AI innovator with proprietary hardware.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is a trending Layer-1 network following the live launch of its fiat anchor with a Stripe company, seamlessly bridging traditional finance with crypto. The community is actively discussing its high-performance, compliance-first architecture, boasting over 11 million transactions per second and a strong focus on Real World Asset tokenization. Many believe KTA is an undervalued infrastructure play poised for significant institutional adoption and robust cross-chain payments.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing a significant rally following exceptionally strong earnings and robust guidance, largely driven by surging demand for High-Bandwidth Memory (HBM) essential for AI data centers. The market is buzzing with bullish sentiment, with many anticipating further price appreciation as memory shifts from a cyclical commodity to a critical, high-margin component in the burgeoning AI landscape. Community discussions highlight strong conviction in its growth potential, comparing it to other successful AI plays amid reports of rising HBM prices and a scramble by big tech for long-term supply.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending amid a volatile market, driven by imminent macro events like the Bank of Japan's rate decision and significant Bitcoin options expiries. Community discussions are highly polarized, with intense debates over historical crypto cycles predicting a downturn versus strong institutional inflows and whale accumulation suggesting bullish resilience. This positions the Bitcoin ETF at the center of evolving sentiment regarding digital asset market structure and adoption.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor Manufacturing is experiencing significant attention due to surging demand for its advanced AI chip manufacturing and CoWoS packaging, with key customers like NVIDIA securing substantial future capacity. The community is actively discussing TSM's indispensable role as the "AI kingmaker" amid reports of capacity expansion and competitive dynamics with Intel. This highlights the company's critical position at the core of the rapidly evolving AI supply chain.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending amid a bullish outlook for U.S. drone manufacturers, fueled by the FCC's immediate implementation of a ban on foreign-made drones and components. The community is buzzing with anticipation for major defense contracts, as a new defense bill is poised to unlock substantial government spending for unmanned aerial and surface systems. Discussions highlight RCAT's production capacity and potential for its Black Widow and Blue Ops USVs to capture significant market share.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is a focal point of discussion, driven by the FDA's approval of Novo Nordisk's oral Wegovy and expectations of a potential partnership that could significantly impact Hims' expanding weight-loss offerings. While proposed legislation concerning compounded GLP-1s and high short interest generate debate, many in the community view recent price movements as a compelling buying opportunity, emphasizing the company's robust fundamentals, institutional backing, and strategic growth into new verticals and international markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, EPIDIOLEX (cannabidiol) oral solution, is commercialized in the U.S. by its U.S. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients one year of age and older. This product has received approval in the European Union under the tradename EPIDYOLEX for the adjunctive treatment of seizures associated with LGS or Dravet syndrome in conjunction with clobazam in patients two years and older and is under EMA review for the treatment of TSC. The Company has a deep pipeline of additional cannabinoid product candidates, in particular nabiximols, for which the Company is advancing multiple late-stage clinical programs in order to seek FDA approval in the treatment of spasticity associated with multiple sclerosis and spinal cord injury. The Company has additional cannabinoid product candidates in clinical trials for autism and schizophrenia.

GWPH
GW Pharmaceuticals plc

Feed

News

Sentiment

Fundamentals

Info

Latest GWPH News

GWPHGW Pharmaceuticals plc